project id: TCGA-BRCA; case submitter id: TCGA-AQ-A1H3; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 9.0; spectrophotometer method: UV Spec; age at index: 49; days to birth: -18177; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1961; age at diagnosis: 18177; ajcc pathologic m: MX; ajcc pathologic n: N3a; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 989.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 94; initial weight: 300.0; oct embedded: false; preservation method: Unknown; sample id: 09191482-34de-4130-afbe-dd47d481d539; sample submitter id: TCGA-AQ-A1H3-01A; portion id: aaa2684e-7a6e-47fc-9d49-3e7d7093f74d; portion submitter id: TCGA-AQ-A1H3-01A-31; slide id: 2b86ba40-96c3-4d04-8e4b-18a547b5c9df; slide submitter id: TCGA-AQ-A1H3-01A-03-TSC; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 80.0; section location: TOP;